De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Envista Holdings Inkomsten in het verleden
Verleden criteriumcontroles 0/6
De winst van Envista Holdings is gedaald met een gemiddeld jaarlijks percentage van -38.5%, terwijl de winst van de Medical Equipment -industrie jaarlijks groeide met 11.8%. De inkomsten zijn groeide met een gemiddeld percentage van 1.4% per jaar.
Belangrijke informatie
-38.5%
Groei van de winst
-41.6%
Groei van de winst per aandeel
| Medical Equipment Groei van de industrie | 8.9% |
| Inkomstengroei | 1.4% |
| Rendement op eigen vermogen | -44.5% |
| Nettomarge | -52.3% |
| Laatste winstupdate | 28 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Envista Holdings Corporation's (NYSE:NVST) Intrinsic Value Is Potentially 51% Above Its Share Price
Oct 07
Envista: $1.2 Billion Asset Impairments Was Fully Priced In
Aug 16Why Investors Shouldn't Be Surprised By Envista Holdings Corporation's (NYSE:NVST) Low P/S
Aug 09Envista Holdings (NYSE:NVST) Has A Somewhat Strained Balance Sheet
Jun 26Envista Q1: Remain Hold Rated Given The Lack Of Positive Catalysts
May 21Envista Holdings Corporation Just Missed Earnings - But Analysts Have Updated Their Models
May 04Is There An Opportunity With Envista Holdings Corporation's (NYSE:NVST) 40% Undervaluation?
Apr 10Envista Holdings (NYSE:NVST) Seems To Use Debt Quite Sensibly
Mar 06Envista Holdings: Rating Downgrade To Hold As Earnings Growth Is Going To Be Weak
Feb 14Returns On Capital At Envista Holdings (NYSE:NVST) Have Stalled
Feb 01Envista Holdings Corporation's (NYSE:NVST) Intrinsic Value Is Potentially 90% Above Its Share Price
Dec 26We Think Envista Holdings (NYSE:NVST) Can Stay On Top Of Its Debt
Nov 17Envista: Still Bullish Considering 2024 Outlook And Inorganic Growth Drivers
Oct 31Returns On Capital At Envista Holdings (NYSE:NVST) Have Hit The Brakes
Oct 27Is Now The Time To Look At Buying Envista Holdings Corporation (NYSE:NVST)?
Sep 25Envista: Consider Revenue Mix And Portfolio Transformation
Aug 22Envista Holdings (NYSE:NVST) Seems To Use Debt Quite Sensibly
Aug 14Returns At Envista Holdings (NYSE:NVST) Appear To Be Weighed Down
Jul 28Envista Holdings Corporation (NYSE:NVST) Shares Could Be 28% Below Their Intrinsic Value Estimate
Jun 28What Is Envista Holdings Corporation's (NYSE:NVST) Share Price Doing?
Jun 09Envista: Weakness In 1Q23 Should Be Done And Dusted
Jun 07We Think Envista Holdings (NYSE:NVST) Can Stay On Top Of Its Debt
May 09Here's What To Make Of Envista Holdings' (NYSE:NVST) Decelerating Rates Of Return
Apr 24Estimating The Intrinsic Value Of Envista Holdings Corporation (NYSE:NVST)
Mar 21Is It Time To Consider Buying Envista Holdings Corporation (NYSE:NVST)?
Mar 06Envista Non-GAAP EPS of $0.52 beats by $0.03, revenue of $660.8M beats by $2.4M
Feb 08Is Envista Holdings (NYSE:NVST) Using Too Much Debt?
Feb 03Envista: Positive Long-Term Outlook
Jan 31Envista Holdings' (NYSE:NVST) Returns Have Hit A Wall
Jan 19Are Investors Undervaluing Envista Holdings Corporation (NYSE:NVST) By 35%?
Dec 20What Does Envista Holdings Corporation's (NYSE:NVST) Share Price Indicate?
Dec 05Envista Non-GAAP EPS of $0.47 in-line, revenue of $631.1M beats by $1.32M
Nov 03Is Envista Holdings (NYSE:NVST) Using Too Much Debt?
Nov 03Envista Holdings (NYSE:NVST) Hasn't Managed To Accelerate Its Returns
Oct 16Is Envista Holdings Corporation (NYSE:NVST) Trading At A 39% Discount?
Sep 10Envista stock rises after Piper Sandler raises rating to overweight
Aug 29Is It Too Late To Consider Buying Envista Holdings Corporation (NYSE:NVST)?
Aug 23Envista Holdings: Not Sinking My Teeth In Yet
Jul 18These 4 Measures Indicate That Envista Holdings (NYSE:NVST) Is Using Debt Safely
Jul 12Envista Holdings Corporation (NYSE:NVST) Shares Could Be 38% Below Their Intrinsic Value Estimate
Jun 03Here's What To Make Of Envista Holdings' (NYSE:NVST) Decelerating Rates Of Return
May 13What Does Envista Holdings Corporation's (NYSE:NVST) Share Price Indicate?
Apr 01Opbrengsten en kosten
Hoe Envista Holdings geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 28 Jun 24 | 2,534 | -1,324 | 1,082 | 89 |
| 29 Mar 24 | 2,563 | -120 | 1,046 | 93 |
| 31 Dec 23 | 2,567 | -100 | 1,029 | 94 |
| 29 Sep 23 | 2,582 | 191 | 1,024 | 98 |
| 30 Jun 23 | 2,582 | 219 | 1,016 | 102 |
| 31 Mar 23 | 2,565 | 211 | 1,023 | 100 |
| 31 Dec 22 | 2,569 | 238 | 1,014 | 100 |
| 30 Sep 22 | 2,560 | 207 | 1,044 | 100 |
| 01 Jul 22 | 2,536 | 238 | 1,028 | 98 |
| 01 Apr 22 | 2,528 | 272 | 1,011 | 99 |
| 31 Dec 21 | 2,509 | 264 | 990 | 101 |
| 01 Oct 21 | 2,473 | 312 | 924 | 99 |
| 02 Jul 21 | 2,413 | 256 | 894 | 95 |
| 02 Apr 21 | 1,995 | 122 | 805 | 78 |
| 31 Dec 20 | 1,929 | 43 | 859 | 87 |
| 02 Oct 20 | 2,033 | 8 | 910 | 99 |
| 03 Jul 20 | 2,145 | 46 | 948 | 115 |
| 03 Apr 20 | 2,639 | 163 | 1,055 | 146 |
| 31 Dec 19 | 2,285 | 184 | 970 | 133 |
| 27 Sep 19 | 2,790 | 213 | 1,055 | 163 |
| 28 Jun 19 | 2,810 | 215 | 1,061 | 169 |
| 29 Mar 19 | 2,832 | 232 | 1,066 | 174 |
| 31 Dec 18 | 2,845 | 231 | 1,113 | 172 |
| 31 Dec 17 | 2,811 | 301 | 1,033 | 172 |
| 31 Dec 16 | 2,785 | 272 | 1,034 | 143 |
Kwaliteitswinsten: NVST is momenteel verliesgevend.
Groeiende winstmarge: NVST is momenteel verliesgevend.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: NVST is verliesgevend en de verliezen zijn de afgelopen 5 jaar toegenomen met een snelheid van 38.5% per jaar.
Versnelling van de groei: Het is niet mogelijk om de winstgroei van NVST over het afgelopen jaar te vergelijken met het gemiddelde over de afgelopen vijf jaar, omdat het bedrijf momenteel verliesgevend is.
Winst versus industrie: NVST is verlieslatend, waardoor het lastig is om de winstgroei van het afgelopen jaar te vergelijken met die van de Medical Equipment industrie ( 7.9% ).
Rendement op eigen vermogen
Hoge ROE: NVST heeft een negatief Return on Equity ( -44.48% ), omdat het momenteel verliesgevend is.